Close Menu

NEW YORK – Investment bank JP Morgan has assigned an Overweight rating to the stocks of both Thermo Fisher Scientific and Qiagen a week after Thermo Fisher's planned acquisition of Qiagen fell through due to resistance from a substantial portion of Qiagen shareholders.

JP Morgan moved to an Overweight rating on both companies from a Not Rated designation assigned during a restriction period as the potential acquisition played out.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.